drug

Vitamin D3

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
DIETARY_SUPPLEMENT
Pre-approval / investigational in the US
Developed by Bronx Psychiatric Center
2 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
DIETARY_SUPPLEMENT

Indications

Trials

2
Vitamin D for Schizophrenia
NCT01759485—Completed
Study of Vitamin D in the Severely Mentally Ill
NCT01169142Phase 4Completed

KOLs & investigators

1
Nigel Bark, MD

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Bronx Psychiatric Center
company
trial
Vitamin D for Schizophrenia
NA
trial
Study of Vitamin D in the Severely Mentally Ill
PHASE4
trial
indication
Schizophrenia
indication
Clozapine Resistant Schizophrenia
indication
Schizophrenia
indication
Psychotic Disorders
indication
KOL
Nigel Bark, MD
KOL score —
person